What Is the Future of Genomic Assays in Toxicology?
The future of genomic assays in toxicology is promising, with ongoing advancements in technology and computational methods. Innovations such as single-cell RNA sequencing and CRISPR-based screens are expanding the capabilities of genomic assays, allowing for more precise investigations of toxicological responses. As these technologies evolve, they will continue to refine our understanding of how genes interact with toxicants, ultimately leading to safer chemical design and better public health outcomes.